Glucagon-Like Peptide-1 Receptor Agonist and the Risk of Pulmonary Aspiration: An Update on Current Recommendations and the Utility of Gastric Ultrasound-Presentation Slides

Presentation Slides

Pdf Summary

This document provides information about the risks of pulmonary aspiration associated with Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) and the use of gastric ultrasonography in preoperative management. It includes learner outcomes focusing on evidence-based recommendations for managing patients on GLP-1RAs and the utility of gastric ultrasonography in assessing gastric contents. The presentation agenda covers the impact and considerations of GLP-1RAs, anesthetic implications, current literature and recommendations, and the utility of point-of-care gastric ultrasound (POCgUS). It also lists various GLP-1RAs brands and their FDA approvals. The presentation emphasizes the importance of utilizing POCgUS to assess gastric contents qualitatively and quantitatively. The document concludes with a reminder to implement training for POCgUS and a section for frequently asked questions regarding its use. Overall, the focus is on increasing awareness of the risks associated with GLP-1RAs and the benefits of incorporating POCgUS in preoperative patient assessment. It aims to provide healthcare professionals with updated recommendations and tools to improve patient safety during anesthesia administration.

Keywords

pulmonary aspiration

GLP-1RAs

gastric ultrasonography

preoperative management

evidence-based recommendations

POCgUS

anesthetic implications

FDA approvals

patient safety

healthcare professionals